BRTX-100

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)NCT04042844BioRestorative TherapiesPhase 2Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.